
Spartan Medical and SI-BONE entered into a new partnership to expand access to ultra–minimally invasive treatment options for Veterans and wounded warriors suffering from sacroiliac (SI) joint dysfunction.
More than 90,000 patients were diagnosed with SI joint dysfunction at VA Medical Centers across the United States in 2024, yet fewer than 0.5% received a long-term solution. This partnership aims to close that gap by bringing SI-BONE’s technologies—most notably the iFuse INTRA X procedure—to VA and DoD facilities nationwide.
The iFuse INTRA X procedure is an ultra-minimally invasive approach utilizing two precision-designed allografts placed percutaneously through a single needle-like incision. These allografts are engineered for intra-articular placement into the SI joint to limit joint motion and support long-term stability.
“We’re honored to bring SI BONE’s groundbreaking SI joint solutions to the federal healthcare community. This partnership directly supports our mission to improve care for Veterans and service members who suffer from chronic pain.” — Vince Proffitt, President, Spartan Medical Inc.
Source: Spartan Medical Inc.
Spartan Medical and SI-BONE entered into a new partnership to expand access to ultra–minimally invasive treatment options for Veterans and wounded warriors suffering from sacroiliac (SI) joint dysfunction.
More than 90,000 patients were diagnosed with SI joint dysfunction at VA Medical Centers across the United States in 2024, yet fewer than...
Spartan Medical and SI-BONE entered into a new partnership to expand access to ultra–minimally invasive treatment options for Veterans and wounded warriors suffering from sacroiliac (SI) joint dysfunction.
More than 90,000 patients were diagnosed with SI joint dysfunction at VA Medical Centers across the United States in 2024, yet fewer than 0.5% received a long-term solution. This partnership aims to close that gap by bringing SI-BONE’s technologies—most notably the iFuse INTRA X procedure—to VA and DoD facilities nationwide.
The iFuse INTRA X procedure is an ultra-minimally invasive approach utilizing two precision-designed allografts placed percutaneously through a single needle-like incision. These allografts are engineered for intra-articular placement into the SI joint to limit joint motion and support long-term stability.
“We’re honored to bring SI BONE’s groundbreaking SI joint solutions to the federal healthcare community. This partnership directly supports our mission to improve care for Veterans and service members who suffer from chronic pain.” — Vince Proffitt, President, Spartan Medical Inc.
Source: Spartan Medical Inc.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





